280 related articles for article (PubMed ID: 8394454)
21. Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia.
Jacobson JG; Ruffner KL; Kosz-Vnenchak M; Hwang CB; Wobbe KK; Knipe DM; Coen DM
J Virol; 1993 Nov; 67(11):6903-8. PubMed ID: 8411396
[TBL] [Abstract][Full Text] [Related]
22. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
23. Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization.
Tenser RB; Dawson M; Ressel SJ; Dunstan ME
Ann Neurol; 1982 Mar; 11(3):285-91. PubMed ID: 6284019
[TBL] [Abstract][Full Text] [Related]
24. A thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo.
Stroop WG; Banks MC; Qavi H; Chodosh J; Brown SM
J Med Virol; 1994 Jul; 43(3):297-309. PubMed ID: 7931192
[TBL] [Abstract][Full Text] [Related]
25. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.
Perng GC; Maguen B; Jin L; Mott KR; Osorio N; Slanina SM; Yukht A; Ghiasi H; Nesburn AB; Inman M; Henderson G; Jones C; Wechsler SL
J Virol; 2002 Feb; 76(3):1224-35. PubMed ID: 11773398
[TBL] [Abstract][Full Text] [Related]
26. Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction.
Friedrich A; Kleim JP; Schneweis KE
Arch Virol; 1990; 113(1-2):107-13. PubMed ID: 2167055
[TBL] [Abstract][Full Text] [Related]
27. Detection of herpes simplex virus type 1 transcripts during latent infection in mice.
Spivack JG; Fraser NW
J Virol; 1987 Dec; 61(12):3841-7. PubMed ID: 2824818
[TBL] [Abstract][Full Text] [Related]
28. Expression of the herpes simplex virus 1 alpha transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice.
Sears AE; Hukkanen V; Labow MA; Levine AJ; Roizman B
J Virol; 1991 Jun; 65(6):2929-35. PubMed ID: 1851865
[TBL] [Abstract][Full Text] [Related]
29. Evidence that the gene for herpes simplex virus type 1 DNA polymerase accounts for the capacity of an intertypic recombinant to spread from eye to central nervous system.
Day SP; Lausch RN; Oakes JE
Virology; 1988 Mar; 163(1):166-73. PubMed ID: 2831653
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia.
Devi-Rao GB; Bloom DC; Stevens JG; Wagner EK
J Virol; 1994 Mar; 68(3):1271-82. PubMed ID: 8107193
[TBL] [Abstract][Full Text] [Related]
31. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
Tenser RB; Gaydos A; Hay KA
J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
[TBL] [Abstract][Full Text] [Related]
32. Establishment of latency in mice by herpes simplex virus 1 recombinants that carry insertions affecting regulation of the thymidine kinase gene.
Sears AE; Meignier B; Roizman B
J Virol; 1985 Aug; 55(2):410-6. PubMed ID: 2991566
[TBL] [Abstract][Full Text] [Related]
33. Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits.
Cook SD; Hill JM; Lynas C; Maitland NJ
Br J Ophthalmol; 1991 Nov; 75(11):644-8. PubMed ID: 1661140
[TBL] [Abstract][Full Text] [Related]
34. Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse.
Ho DY; Mocarski ES
Virology; 1988 Nov; 167(1):279-83. PubMed ID: 2847416
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo.
Bloom DC; Devi-Rao GB; Hill JM; Stevens JG; Wagner EK
J Virol; 1994 Mar; 68(3):1283-92. PubMed ID: 8107194
[TBL] [Abstract][Full Text] [Related]
36. High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation.
Perng GC; Ghiasi H; Slanina SM; Nesburn AB; Wechsler SL
J Virol; 1996 May; 70(5):2883-93. PubMed ID: 8627763
[TBL] [Abstract][Full Text] [Related]
37. Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model.
Spivack JG; Fareed MU; Valyi-Nagy T; Nash TC; O'Keefe JS; Gesser RM; McKie EA; MacLean AR; Fraser NW; Brown SM
J Gen Virol; 1995 Feb; 76 ( Pt 2)():321-32. PubMed ID: 7844554
[TBL] [Abstract][Full Text] [Related]
38. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.
Ramakrishnan R; Levine M; Fink DJ
J Virol; 1994 Nov; 68(11):7083-91. PubMed ID: 7933090
[TBL] [Abstract][Full Text] [Related]
39. In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice.
Mehta A; Maggioncalda J; Bagasra O; Thikkavarapu S; Saikumari P; Valyi-Nagy T; Fraser NW; Block TM
Virology; 1995 Jan; 206(1):633-40. PubMed ID: 7831818
[TBL] [Abstract][Full Text] [Related]
40. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.
Leib DA; Harrison TE; Laslo KM; Machalek MA; Moorman NJ; Virgin HW
J Exp Med; 1999 Feb; 189(4):663-72. PubMed ID: 9989981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
